RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI) TARACAN: Targeted Radionuclide Therapy for disseminated cancer
South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) Theranostic radiopharmaceuticals for metastatic cancer
South-Eastern Norway Regional Health Authority (2019-2024) A novel PET-based prediction platform for myeloma patients
South-Eastern Norway Regional Health Authority and CarciNor (2018-24) Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
Civitan, The Alzheimer Research Fund (2018-2023) Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels
Holt MF, Michelsen AE, Flø A, Russell K, Beitnes JO, Kløve SF, Hodt A, Gullestad L, Aukrust P, Gude E, Broch K, Ueland T(2025) Increased dipeptidyl peptidase 4 in patients with concomitant transthyretin cardiac amyloidosis and severe aortic stenosis Int J Cardiol Heart Vasc, 61, 101820 DOI 10.1016/j.ijcha.2025.101820, PubMed 41141478
Ramberg H, Zucknick M, Barletta F, Davik P, Nybøen Å, Eri LM, Sivanesan S, Hole KH, Hompland T, Prestbakk SO, Gandaglia G, Bathen TF, Briganti A, Berge V, Austild Tasken K(2025) Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients Acta Oncol, 64, 1446-1454 DOI 10.2340/1651-226X.2025.43970, PubMed 41123130
Neilsen BK, Huang RR, Valle LF, Proudfoot JA, Davicioni E, Zhang L, Ryg U, Schulz-Jaavall M, Weidhaas JB, Santoso M, Parmisano S, Calais J, Reiter RE, Rettig MB, Steinberg ML, Sisk A, Brisbane W, Marks LS, Boutros PC, Lilleby WH, Kishan AU(2025) Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer Int J Radiat Oncol Biol Phys(in press) DOI 10.1016/j.ijrobp.2025.09.035, PubMed 41105052